Pfizer, Inc. Press Releases

PFE 
$31.96
*  
0.01
0.03%
Get PFE Alerts
*Delayed - data as of Dec. 19, 2014 13:14 ET  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    PFE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia
12/18/2014 8:00:00 AM - Business Wire
▲1.78 % Price Change since this news event. The Volume Ratio is 1.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


EnLink Midstream Begins Open Season for Ohio River Valley Condensate Pipeline System Project
12/17/2014 8:00:00 AM - Business Wire


Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts
12/16/2014 10:00:00 AM - Business Wire
▲3.40 % Price Change since this news event. The Volume Ratio is 0.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis
12/16/2014 8:00:00 AM - Business Wire
▲4.14 % Price Change since this news event. The Volume Ratio is 0.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology
12/15/2014 6:30:00 PM - Business Wire
▲3.70 % Price Change since this news event. The Volume Ratio is 0.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Declares First-Quarter 2015 Dividend
12/15/2014 12:06:00 PM - Business Wire
▲3.80 % Price Change since this news event. The Volume Ratio is 1.51.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


InvestorsObserver releases comments on Pfizer, FedEx, Nike, General Mills, and DR Horton
12/15/2014 9:31:00 AM - PR Newswire


OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP)
12/15/2014 8:00:00 AM - Business Wire
▲2.70 % Price Change since this news event. The Volume Ratio is 1.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Actavis Launches Generic Version of Celebrex®
12/10/2014 9:28:00 AM - PR Newswire


AV1 Group Releases Update to Shareholders on Recent Developments and Strategies
12/10/2014 9:00:00 AM - Market Wire


ADP Regional Employment Report: All Four Major Regions Add Fewer Jobs in November Than Previous Six-Month Average
12/10/2014 9:00:00 AM - Market Wire


New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers
12/9/2014 10:30:00 AM - Business Wire
▲0.85 % Price Change since this news event. The Volume Ratio is 1.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects
12/8/2014 1:30:00 PM - Business Wire
▼-0.06 % Price Change since this news event. The Volume Ratio is 3.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.
12/8/2014 8:06:00 AM - PR Newswire


Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
12/4/2014 11:29:00 AM - PR Newswire


Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
12/4/2014 10:00:00 AM - PR Newswire


Phase 3 Results Published in The New England Journal of Medicine Show Superiority of Pfizer’s XALKORI® (crizotinib) Compared to Platinum-Based Chemotherapy in Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer
12/3/2014 5:07:00 PM - Business Wire
▲0.72 % Price Change since this news event. The Volume Ratio is 1.03.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Diplomat selected as a limited-distribution pharmacy partner by Pfizer; Diplomat to dispense Xalkori®, Bosulif®, Sutent® and Inlyta®
12/3/2014 4:37:00 PM - PR Newswire


New Survey Finds Majority of Women with Breast Cancer Who Work Want to Do So Even While Undergoing Treatment
12/2/2014 8:00:00 AM - Business Wire
▲2.04 % Price Change since this news event. The Volume Ratio is 1.34.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Completes Acquisition of Baxter’s Marketed Vaccines
12/1/2014 7:30:00 AM - Business Wire
▲2.60 % Price Change since this news event. The Volume Ratio is 1.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Papa John’s Accelerates International Growth in India
11/24/2014 8:30:00 PM - Business Wire


Nodality Develops Disease-Associated PD-1 Assay System for Application in Immuno-oncology
11/19/2014 8:00:00 AM - Business Wire


Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research
11/18/2014 9:00:00 AM - PR Newswire


TRUMENBA® (Meningococcal Group B Vaccine) is Now Available
11/18/2014 8:30:00 AM - Business Wire


Nodality, Inc. Announces Data Presentation from Collaborative Program with UCB at American College of Rheumatology 2014 Annual Meeting
11/18/2014 8:00:00 AM - Business Wire